Long-acting reversible contraceptives were associated with an increased risk of type 2 diabetes in obese women. Data on three types of birth-control methods showed women who had progestin-releasing LARC devices implanted under the skin had a 10% increase in fasting blood glucose levels, compared with a 5% increase in those who used a progestin-releasing IUD and a 2% decrease in those who opted for non-hormonal contraceptives. Contraception, Feb 2013
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.